Evaluation of left ventricular function in long-term survivors of childhood Hodgkin disease

Pediatric Blood and Cancer

Volumn 45, Issue 5, 2005, Pages 700-705

  Iarussi, Diana ^a,c   Pisacane, Carlo ^a   Indolfi, Paolo ^b   Casale, Fiorina ^b   Martino, Vincenzo ^a   Di Tullio, Maria Teresa ^b  

^a Cattedra di Cardiologia   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c NONE   (Italy)

Author keywords

Cardiology; Cardiotoxicity; General; Hodgkin disease

Indexed keywords

BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; AGE; ARTICLE; BODY MASS; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART PERFORMANCE; HEART RATE; HODGKIN DISEASE; HUMAN; M MODE ECHOCARDIOGRAPHY; MALE; PRIORITY JOURNAL; RADIATION DOSE; SYSTOLIC BLOOD PRESSURE;

EID: 24644439959     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20213     Document Type: Article

References (33)

1. De Vita VT, Canellos GP, Mowley JH. A decade of combination chemotherapy for advanced Hodgkin disease. Cancer 1972;30: 1495-1504.
2. Bonadonna G. Chemotherapy strategies to improve the control of Hodgkin disease. Cancer Res 1982;42:4309-4320.
3. Green DM, Hyland A, Chung CS, et al. Cancer and cardiac mortality among 15-year survivors of cancer diagnosed during childhood or adolescence. J Clin Oncol 1999;17:3207-3215.
4. Gomez GA, Park JJ, Panahon A, et al. Heart size and function after radiation therapy to the mediastinum in patients with Hodgkin disease. Cancer Treat Rep 1983;67:1099-1103.
5. Morgan GW, Freeman AP, Mclean RG, et al. Late cardiac, thyroid, and pulmonary sequelae of mantle radiotherapy for Hodgkin disease. Int J Radiat Oncol Biol Phys 1985;11:1925-1931.
6. Green DM, Gingell RL, Pearce J, et al. The effect of mediastinal irradiation on cardiac function of patients treated during childhood and adolescence for Hodgkin disease. J Clin Oncol 1987;5:239-245.
7. Gustavsson A, Eskilsson T, Landberg T, et al. Late cardiac effects after mantle radiotherapy in patients with Hodgkin disease. Ann Oncol 1990;1:355-363.
8. Constine LS, Schwartz RG, Savage DE, et al. Persistence of normal cardiac function in irradiated long-term survivors of Hodgkin disease. Int J Radiat Oncol Biol Phys 1996;36(Suppl 1):171.
9. Ilhan I, Sarialioglu F, Ozbarlas N, et al. Late cardiac effects after treatment for childhood Hodgkin disease with chemotherapy and low-dose radiotherapy. Postgrad Med J 1995;71:164-167.
10. Glanzmann C, Kaufmann P, Jenni R, et al. Cardiac risk after mediastinal irradiation for Hodgkin disease. Radiother Oncol 1998;46:51-62.
11. Tei C, Ling LH, Hodge DO, et al. New index of combined systolic and diastolic myocardial performance: A simple and reproducible measure of cardiac function - a study in normal and dilated cardiomyopathy. J Cardiol 1995;26:357-366.
12. Tei C. New non-invasive index of combined systolic and diastolic ventricular function. J Cardiol 1995;26:396-404.
13. Tei C, Dujardin KS, Hodge DO, et al. Doppler index combining systolic and diastolic myocardial performance: Clinical value in cardiac amyloidosis. J Am Coll Cardiol 1996;28:658-664.
14. Dujardin KS, Tei C, Yeo TC, et al. Prognostic value of Doppler-index combining systolic and diastolic performance in idiopathic-dilated cardiomyopathy. Am J Cardiol 1998;82:1071-1076.
15. Poulsen SH, Jensen SE, Tei C, et al. Value of the Doppler index of cardiac performance in the early phase of acute myocardial infarction. J Am Soc Echocardiogr 2000;13:723-730.
16. Ishii M, Tsutsumi T, Himeno W, et al. Sequential evaluation of left ventricular myocardial performance in children after anthracycline therapy. Am J Cardiol 2000;86:1279-1281.
17. Sato T, Harada K, Tamura M, et al. Cardiorespiratory exercise capacity and its relation to a new Doppler index in children previously treated with anthracycline. J Am Soc Echocardiogr 2001;14:256-263.
18. Tei C, Nishimura R, Seward JB, et al. Non-invasive Doppler-derived myocardial performance index. Correlation with simultaneous measurement of cardiac catheterization measurements. J Am Soc Echocardiogr 1997;10:169-178.
19. Eto G, Ishii M, Tei C, et al. Assessment of global left ventricular function in normal children and in children with dilated cardiomyopathy. J Am Soc Echocardiogr 1999;12:1058-1064.
20. Sahn DJ, DeMaria A, Kisslo J, et al. The Committee on M-Mode Standardization of the American Society for Echocardiography. Recommendations regarding quantitation in M-mode echocardiography; results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083.
21. Devereux RB, Reicheck N. Echocardiographic determination of left ventricular mass: Anatomic validation of the method. Circulation 1977;55:613-618.
22. Nishimura RA, Abel MD, Hatle LK, et al. Assessment of diastolic function of the heart: Background and current applications of Doppler echocardiography (Part II: clinical studies). Mayo Clin Proc 1989;64:181-204.
23. Appleton CP, Hatle LA, Popp RL. Relation of transmitral flow velocity patterns to left ventricular diastolic function: New insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol 1988;12:426-440.
24. Salloum E, Tanoue LT, Wackers FJ, et al. Assessment of cardiac and pulmonary function in adult patients with Hodgkin disease treated with ABVD or MOPP/ABVD plus adjuvant low-dose mediastinal irradiation. Cancer Invest 1999;17:171-180.
25. Bruch C, Schmermund A, Marin D, et al. Tei index in patients with mild to moderate congestive heart failure. Eur Heart J 2000;21: 1888-1895.
26. Bruch C, Schmermund A, Dagres N, et al. Severe aortic valve stenosis with preserved and reduced systolic left ventricular function: Diagnostic usefulness of the Tei index. J Am Soc Echocardiography 2002;15:869-876.
27. Haque A, Otsuji Y, Yoshifuku S, et al. Effects of valve dysfunction on Doppler Tei index. J Am Soc Echocardiography 2002;15:877-883.
28. Lipshultz SE, Colan SD, Gelber RD, et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 1991;324:808-815.
29. Steinherz LJ, Steinherz PG, Tan CTC, et al. Cardiac toxicity 4-20 years after completing anthracycline therapy. JAMA 1991;266: 1672-1677.
30. Iarussi D, Indolfi P, Pisacane C, et al. Comparison of left ventricular function by echocardiogram in patients with Wilms' tumor treated with anthracycline versus those not so treated. Am J Cardiol 2003; 92:359-361.
31. Gilladoga AC, Manuel C, Tan CTC, et al. The cardiotoxicity of adriamycin and daunomycin in children. Cancer 1976;37:1070-1078.
32. Harada K, Suzuki T, Tamura M, et al. Role of age on transmitral flow velocity patterns in assessing left ventricular diastolic function in normal infants and children. Am J Cardiol 1995;76:530-532.
33. Harada K, Takahashi Y, Shiota T, et al. Effect of heart rate on left ventricular diastolic filling patterns assessed by Doppler echocardiography in normal infants. Am J Cardiol 1995;76:634-636.